Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Sagimet Biosciences (SGMT) Non Operating Income (2023 - 2024)

Sagimet Biosciences (SGMT) has 2 years of Non Operating Income data on record, last reported at $2.0 million in Q4 2024.

  • For Q4 2024, Non Operating Income rose 51.63% year-over-year to $2.0 million; the TTM value through Dec 2024 reached $8.9 million, up 210.3%, while the annual FY2025 figure was $5.9 million, 34.16% down from the prior year.
  • Non Operating Income reached $2.0 million in Q4 2024 per SGMT's latest filing, down from $2.3 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $2.5 million in Q2 2024 and bottomed at $178000.0 in Q1 2023.